The Role of Sex in Survival for Small Cell Lung Cancer
Author Information
Author(s): M. Wolf, R. Holle, K. Hans, P. Drings, K. Havemann
Primary Institution: Philipps-University of Marburg
Hypothesis
Does gender serve as an independent prognostic factor for survival in small cell lung cancer?
Conclusion
Female patients with small cell lung cancer have better survival rates than male patients, particularly those under 60 years old.
Supporting Evidence
- Female patients had a higher complete remission rate of 35% compared to 25% for males.
- Median survival for females was 12.1 months, while for males it was 9.8 months.
- Women under 60 years had a median survival of 13.3 months compared to 10.1 months for men.
Takeaway
Women with small cell lung cancer tend to live longer than men, especially if they are younger than 60.
Methodology
Data from three multicenter trials were analyzed to evaluate the impact of sex on survival in small cell lung cancer patients.
Potential Biases
The study may be influenced by the small number of female patients and the varying treatment responses based on age.
Limitations
The study's findings may not apply to older women, as no survival advantage was observed in that group.
Participant Demographics
652 male and 114 female patients, with a minimum follow-up of 36 months.
Statistical Information
P-Value
0.0001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website